Effect of insulin-resistance on circulating and adipose tissue MMP-2 and MMP-9 activity in rats fed a sucrose-rich diet

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 3, 2014, Pages 294-300

  Miksztowicz, V ^a   Morales, C ^b   Zago, V ^a   Friedman, S ^a   Schreier, L ^a   Berg, G ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b University of Buenos Aires   (Argentina)

Author keywords

Adipose tissue; Atherosclerotic plaque; Insulin resistance; Metalloproteinase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID; GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUCROSE; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; X RAY SPECTROMETRY; ZYMOGRAPHY;

RATTUS; RATTUS NORVEGICUS;

ADIPOSE TISSUE; ATHEROSCLEROTIC PLAQUE; INSULIN-RESISTANCE; METALLOPROTEINASE;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIETARY SUCROSE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INSULIN; INSULIN RESISTANCE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PPAR GAMMA; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84895799075     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.08.007     Document Type: Article

References (30)

1. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573.
2. Vu T.H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000, 14:2123-2133.
3. Lu M., Rabie A.B. Matrix metalloproteinase-9 regulates graft bone resorption. Angle Orthod 2006, 76:598-604.
4. Roy R., Zhang B., Moses M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 2006, 312:608-622.
5. Li Z., Li L., Zielke H.R., Cheng L., Xiao R., Crow M.T., et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerosis lesions. Am J Pathol 1996, 148:121-128.
6. Schönbeck U., Mach F., Sukhova G.K., Atkinson E., Levesque E., Herman M., et al. Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med 1999, 189:843-853.
7. Uzui H., Harpf A., Liu M., Doherty T.M., Shukla A., Chai N.N., et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque. Role of activated macrophages and inflammatory cytokines. Circ Res 2002, 106:3024-3030.
8. de Nooijer R., Verkleij C.J., von der Thüsen J.H., Jukema J.W., van der Wall E.E., van Berkel T.J., et al. Lesional overexpression of matrix metalloproteinase-9 promotes intra-plaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 2006, 26:340-346.
9. Choudhary S., Higgins C.L., Chen I.Y., Reardon M., Lawrie G., Vick G.W., et al. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 2006, 26:2351-2358.
10. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
11. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008, 37:635-646.
12. Maquoi E., Munaut C., Colige A., Collen D., Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002, 51:1093-1101.
13. Christiaens V., Lijnen H.R. Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem 2006, 112:254-259.
14. Chavey C., Mari B., Monthouel M.N., Bonnafous S., Anglard P., Van Obberghen E., et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003, 278:11888-11896.
15. Gutman R., Basílico M., Bernal C., Chicco A., Lombardo Y. Long-Term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose rich diet. Metabolism 1987, 36:1013-1020.
16. Ferreira M.R., Camberos M.del C., Selenscig D., Martucci L.C., Chicco A., Lombardo Y.B., et al. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats. Clin Exp Pharmacol Physiol 2013, 40(3):205-211.
17. Monti L.D., Galluccio E., Lucotti P., Setola E., Costa S., Fontana B., et al. Beneficial role of L-arginine in cardiac matrix remodelling in insulin resistant rats. Eur J Clin Invest 2008, 38(11):849-856.
18. Ivanova M., Janega P., Matejikova J., Simoncikova P., Pancza D., Ravingerova T., et al. Activation of Akt kinase accompanies increased cardiac resistance to ischemia/reperfusion in rats after short-term feeding with lard-based high-fat diet and increased sucrose intake. Nutr Res 2011, 31(8):631-643.
19. Martinez Calejman C., Di Gruccio J.M., Mercau M.E., Repetto E.M., Astort F., Sanchez R., et al. Insulin sensitization with a peroxisome proliferator-activated receptor γ agonist prevents adrenocortical lipid infiltration and secretory changes induced by a high-sucrose diet. J Endocrinol 2012, 214(3):267-276.
20. Institute of Laboratory Animal Resources CoLS National research council guide for the care and use of laboratory animals 1996, 125. National Academy Press, Washington. 7th ed.
21. 2. Clin Chem 1983, 29:2026-2030.
22. Cacho J., Sevillano J., de Castro J., Herrera E., Ramos M. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 2008, 295:1269-1276.
23. Kleiner D.E., Stetler-Stevenson W.G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994, 218:325-329.
24. Blankenberg S., Rupprecht H.J., Poirier O., Bickel C., Smieja M., Hafner G., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003, 107:1579-1585.
25. Kobayashi N., Hata N., Kume N., Yokoyama S., Shinada T., Tomita K., et al. Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome. Circ J 2011, 75:2853-2861.
26. Lijnen H.R., Maquoi E., Hansen L.B., Van Hoef B., Frederix L., Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002, 22:374-379.
27. Lijnen H. Angiogenesis and obesity. Cardiovasc Res 2008, 78:286-293.
28. Boden G., Song W., Pashko L., Kresge K. In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta. Diabetes 2008, 57:476-483.
29. Miksztowicz V., Muzzio M.L., Royer M., Prada M., Wikinski R., Schreier L., et al. Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome. Metabolism 2008, 57:1493-1496.
30. Gummesson A., Hagg D., Olson F.J., Hulthe J., Carlsson L.M., Fagerberg B. Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation. Scand J Clin Lab Invest 2009, 69:636-642.